Resultado de búsqueda
Hace 12 horas · Los investigadores del centro de investigación Breast Cancer Now Toby Robins ... una biopsia líquida que permite detectar la aparición de tumores de mama/Archivo Johns Hopkins Kimmel Cancer ...
Hace 3 días · In this phase 1 trial, treatment of patients with ER+HER2− metastatic breast cancer with a selective catalytic inhibitor of the lysine acetyltransferase KAT6 shows a manageable safety profile ...
Hace 1 día · UNIQUE VARIANTS—AND RISKS . T hough Black and white women have similar breast cancer incidence rates, Black women are more than 40% more likely to die from the disease. They develop more aggressive breast cancer tumors and are diagnosed younger. Epidemiologists have associated environmental factors such as neighborhood deprivation, exposure to pollutants, and racism with more aggressive ...
Hace 1 día · We read with interest the final overall survival (OS) analysis from MONARCH 3, comparing abemaciclib plus nonsteroidal aromatase inhibition with placebo plus aromatase inhibition among patients with hormone-receptor-positive advanced breast cancer.1 The authors reported that the addition of abemaciclib resulted in a clinically meaningful improvement in OS, although the stratified log-rank test ...
Hace 5 días · A Johns Hopkins University-led research team has designed a method to generate enormous datasets of artificial, automatically annotated liver tumors on CT scans, enabling artificial intelligence models to be trained to accurately identify real tumors without human help.
Hace 1 día · Hodgkin lymphoma. A comparison of two chemotherapy regimens for advanced Hodgkin lymphoma found the less intensive treatment was more effective for the blood cancer and caused fewer side effects ...
Hace 1 día · Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ... To further investigate the potential use of EVs as a source of breast cancer biomarkers, we have discussed the use of these proteins as predictive marker candidates.
